Analyst firm downgraded the stock rating of TruBridge on July 1, 2026.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firm downgraded the stock rating of TruBridge on July 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
- Rating firms Raymond James Financial, Cantor Fitzgerald, and Truist Financial issued updates, including buy ratings and price targets, for First Industrial Realty Trust on June 19, 2026.
- Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.
Related events
- Cantor Fitzgerald and Jefferies Financial Group downgraded EyePoint Pharmaceuticals' stock rating from overweight/buy to neutral/hold on October 19, 2026.
- MarketBeat reported the stock's average rating while Citigroup reiterated a buy rating and Cantor Fitzgerald restated an overweight rating for Beta Technologies.
- Cantor Fitzgerald lowered its price target on MARA stock on October 21, 2026.
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Briefing.com reported a rating change issued by Cantor Fitzgerald.